Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Baseline Values of Renal Prognosis-related Factors on Their Changes after Initiating Tofogliflozin Treatment: A Retrospective Study in Japanese Patients with Type 2 Diabetes and Renal Impairment.
Matsumoto S, Ito H, Inoue H, I C, Miura S, Antoku S, Yamasaki T, Mori T, Togane M. Matsumoto S, et al. Among authors: togane m. JMA J. 2024 Oct 15;7(4):571-579. doi: 10.31662/jmaj.2024-0128. Epub 2024 Sep 6. JMA J. 2024. PMID: 39513071 Free PMC article.
Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes.
Ito H, Matsumoto S, Izutsu T, Kusano E, Nishio S, Antoku S, Yamasaki T, Mori T, Togane M, Ando S, Tsugami E. Ito H, et al. Among authors: togane m. Diabetes Metab Syndr Obes. 2019 Sep 9;12:1783-1794. doi: 10.2147/DMSO.S221655. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31571954 Free PMC article.
Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation.
Ito H, Matsumoto S, Izutsu T, Kusano E, Kondo J, Inoue H, Antoku S, Yamasaki T, Mori T, Togane M. Ito H, et al. Among authors: togane m. PLoS One. 2021 Mar 15;16(3):e0248577. doi: 10.1371/journal.pone.0248577. eCollection 2021. PLoS One. 2021. PMID: 33720983 Free PMC article. Clinical Trial.
Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin.
Ito H, Inoue H, Izutsu T, Matsumoto S, Antoku S, Yamasaki T, Mori T, Togane M. Ito H, et al. Among authors: togane m. PLoS One. 2023 Sep 21;18(9):e0292014. doi: 10.1371/journal.pone.0292014. eCollection 2023. PLoS One. 2023. PMID: 37733761 Free PMC article.
The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study.
Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, Togane M. Ito H, et al. Among authors: togane m. Cardiovasc Diabetol. 2010 May 15;9:18. doi: 10.1186/1475-2840-9-18. Cardiovasc Diabetol. 2010. PMID: 20470427 Free PMC article.
Comparison of the antidiabetic effects of linagliptin among groups with a normal renal function and a mild or severe renal impairment - retrospective observation study of Japanese patients with type 2 diabetes mellitus.
Ito H, Abe M, Antoku S, Omoto T, Shinozaki M, Nishio S, Mifune M, Togane M. Ito H, et al. Among authors: togane m. Expert Opin Pharmacother. 2015 Feb;16(3):289-96. doi: 10.1517/14656566.2015.995091. Epub 2014 Dec 22. Expert Opin Pharmacother. 2015. PMID: 25529857
32 results